Ascendia’s facility is located in North Brunswick, NJ. We have formulation development and analytical testing laboratories in which we conduct our prototype screening, product development, physical property characterization activities, method development, method validation and stability testing.

Ascendia has Class 10,000 (ISO 7) and Class 100 (ISO 5) cleanrooms for conducting cGMP manufacture of sterile injectable products, and Class 10,000 manufacturing suites for production of oral dosage forms. Ascendia is qualified to produce Phase I/II clinical trial materials - both for formulations developed by Ascendia and for formulations transferred to Ascendia.

We have a wide variety of equipment for

producing pharmaceutical formulations:

  • Fluid-bed granulation and coating
  • Micro-fluidizer
  • Roller compaction
  • Conical mill
  • Tablet compression
  • Capsule filling
  • Spray dryer
  • High pressure homogenizer
  • Covaris sonicator
  • Hot-melt extrusion
  • Solvent evaporation
  • Nano-particle bead-milling
  • Lyophilization
  • Autoclave
  • Isolation hoods for cytotoxics

Our analytical instrumentation for testing pharmaceutical formulations:

  • HPLC and UPLC (Empower 3)
  • GC
  • LCMS
  • FT-IR
  • Karl Fischer moisture determination
  • USP Dissolution
  • Differential scanning calorimetry (DSC)
  • Particle size distribution analysis
  • NMR and XRPD
  • Total Organic Carbon (TOC) Analyzer
  • Charge Aerosol Detector (CAD)
  • Finished dosage form testing: density, hardness; friability, disintegration, viscosity, etc.
  • ICH stability chambers
  • Stability chambers
Sign Up Now For Updates